Abridge
Research Team Data
Published
Care intelligence at the point of conversation
Company profile
Overview
Generative AI platform for clinical conversations, documentation and healthcare workflow intelligence.
Abridge listens to clinical conversations and generates structured clinical documentation, coding support and downstream healthcare workflow artifacts with clinician oversight.
At a glance
Key facts
- HQ location
- Pittsburgh, PA, USA
- Founded
- 2018
- Employee range
- 501-1000
- Funding stage
- Series C Plus
- Company type
- Private
- Last updated
- Pricing model
- SubscriptionUsage BasedEnterprise SaaS subscription / usage
Business context
Financials
- Revenue estimate
- ~$100M ARR / $117M contracted ARR estimate; not company-confirmed
- Valuation estimate
- $5.3B valuation (2025 Series E)
- Investments
- ~$800M+ total funding; $300M Series E announced Jun 2025 after $250M raise Feb 2025
Market context
Relationships
- Target customers
- Health systems, physicians, nurses and clinical operations teams
- Key competitors
- Microsoft Nuance, Suki, Nabla, Ambience Healthcare, Notable
- Known customers
- 150+ U.S. health systems; Yale New Haven Health, University of Kansas Health System, UPMC, Inova Health
Source context
Classification (raw research text)
- Core focus
- Clinical GenAI and documentation workflows
- Core industry
- Healthcare Technology
- Core category
- Clinical AI documentation platform
Shown verbatim from the research spreadsheet — deriving structured industry tags from this text is a future phase.
Market taxonomy
Segments, Industries & Certifications
Segments
AI WorkflowsDocument AIAI Quality & ObservabilityTraditional MLAI Governance & RiskCall AnalysisSTT/TTS Infrastructure
Industries
Healthcare